Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,351.30INR
10:21am GMT
Change (% chg)

Rs1.50 (+0.11%)
Prev Close
Rs1,349.80
Open
Rs1,360.00
Day's High
Rs1,360.00
Day's Low
Rs1,328.00
Volume
9,775
Avg. Vol
40,130
52-wk High
Rs1,800.05
52-wk Low
Rs1,010.00

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 8,215.00 8,215.00 8,215.00 --
Year Ending Mar-18 9 30,763.50 32,896.20 29,140.00 --
Year Ending Mar-19 9 33,152.40 37,704.90 31,873.00 36,260.00
Year Ending Mar-20 8 36,746.40 39,698.00 34,643.00 39,335.00
Earnings (per share)
Year Ending Mar-18 9 21.16 24.55 18.75 --
Year Ending Mar-19 9 26.57 30.65 22.53 26.62
Year Ending Mar-20 8 31.42 39.55 25.21 29.08
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 31.23 33.59
P/E High - Last 5 Yrs. -- 40.67 45.05
P/E Low - Last 5 Yrs. -- 24.06 24.37
Beta 0.17 0.92 0.91
Price to Sales (TTM) 14.01 4.01 5.69
Price to Book (MRQ) -- 5.04 5.11
Price to Tangible Book (MRQ) -- 5.77 6.54
Price to Cash Flow (TTM) 174.34 23.28 23.52
% Owned Institutions -- 0.96 1.86

Dividends

  Company industry sector
Dividend Yield 1.24 1.54 1.48
Dividend Yield - 5 Year Avg -- 1.55 1.50
Dividend 5 Year Growth Rate -- 4.20 5.09
Payout Ratio(TTM) 0.00 45.75 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.38 7.42
Sales (TTM) vs TTM 1 Yr. Ago -- 4.87 5.86
Sales - 5 Yr. Growth Rate -- 10.03 10.16
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 17.59 21.17
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.81 10.63
Capital Spending - 5 Yr. Growth Rate -- 15.39 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.26
Current Ratio (MRQ) -- 3.02 3.09
LT Debt to Equity (MRQ) -- 8.92 11.53
Total Debt to Equity (MRQ) -- 12.75 15.71
Interest Coverage (TTM) -- 35.11 32.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 54.28 54.07
Gross Margin - 5 Yr. Avg. -- 51.72 51.83
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 18.38 11.80
Operating Margin (TTM) 33.89 14.42 4.85
Operating Margin - 5 Yr. Avg. -- 14.54 7.45
Pre-Tax Margin (TTM) 33.89 14.94 5.82
Pre-Tax Margin - 5 Yr. Avg. -- 14.96 7.86
Net Profit Margin (TTM) 23.12 11.15 2.08
Net Profit Margin - 5 Yr. Avg. -- 11.22 4.10
Effective Tax Rate (TTM) 31.77 23.47 23.39
Effective Tax Rate - 5 Yr. Avg. -- 23.63 24.13

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 1,003,835,245 905,634,050
Net Income/Employee (TTM) 718,922 119,027,143 107,327,020
Receivable Turnover (TTM) -- 5.83 5.95
Inventory Turnover (TTM) -- 2.68 3.63
Asset Turnover (TTM) -- 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 12.00 11.52
Return on Assets - 5 Yr. Avg. -- 13.31 12.71
Return on Investment (TTM) -- 15.57 15.05
Return on Investment - 5 Yr. Avg. -- 17.33 16.50
Return on Equity (TTM) -- 16.94 16.62
Return on Equity - 5 Yr. Avg. -- 18.26 17.61
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 20
13 Week -6.52 -7.86 99 34
26 Week -11.71 -17.56 99 28
52 Week -17.27 -26.91 99 11
YTD -11.53 -25.96 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.57%
# of Holders: 19
Total Shares Held: 19,593,327
3 Mo. Net Change: -116,886
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 4
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.